Published 102 days ago
In this video from the storming success that was the 2017 UK Investor Show, John Dawson, CEO of Alliance Pharma (APH), is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.
Published 433 days ago
Alliance Pharma (APH) has, relatively, recently completed a transformational acquisition. I know that Nigel Wray remains a big fan as does Mark Slater. Sensible value investors should thus find the presentation by John Dawson of interest
Published 809 days ago
Amiong those presenting in the healthcare and biotech master class were John Dawson of Alliance Pharma, Steve Moore, Adam Reynolds of Premaitha and Optibiotix, Venn Life and Collagen. Enjoy
Published 827 days ago
Alliance Pharma (APH) is a stock that Britain’s Buffett had held for ten years and it is also a great sleep-sound core portfolio buy for me. Its CEO John Dawson is a good man and I like the company. Anyhow he, and the CEOs of Rex Bionics, Accesso and Akers Biosciences, of which I know sweet FA are presenting in London at the Proactive forum this Thursday 23rd). There’s free food & booze on offer as well. And